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The relationship between the antioxidant effects of reduced coenzyme Q,, (ubiquinol, UQH,) and vitamin E (or-tocopherol) was investigated in 
beef heart submitochondeial particles in which lipid peroxidation was initiated by incubation with ancorbatei-AD&Fe’+. These effects were exam- 
ined after extraction of coenzyme Q,, @Q-IO) and vitamin E from the particles and reincorporation of the same components alone or in combina- 
tion. The results show that UQH, efficiently inhibits lipid peroxidation even when vitamin E is absent. It is concluded that UQH2 can inhibit lipid 
peroxidation directly, without the mediation of vitamin E. 
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1. INTRODUCTION 
Over the last three decades evidence has accumulated 
which strongly suggests that coenzyme Q (ubiquinone; 
UQ) in its reduced form acts as an antioxidant in- 
hibiting lipid peroxidation in model systems [l-8] and 
in biological membranes in vitro [2,3,9-153 alld in vivo 
[14,16,17]. Although the precise mechanism of this ef- 
fect is not yet known, it has been suggested [l&19] that 
UQH2 may act by quenching lipid peroxyl (LOO.), 
alkoxyl (1.0.) or carbon based lipid radicals (L*), or 
lipid peroxidation initiating species such as the perferryl 
radical (Fe3 + -02 - ‘), Alternatively, it has recently been 
proposed 1203 that UQHz inhibits lipid peroxidation 
merely in an indirect fashion, by maintaining vitamin E 
(cr-tocopherol), in its reduced form, i.e. by regenerating 
vitamin E from the a-tocopheroxyl radical (E.) formed 
during its antioxidant function, which otherwise is com- 
monly attributed to water-soluble reducing agents such 
as ascorbate or glutathione (see (211 for review). 
tioxidant effect cannot be due exclusively to the 
maintenance of vitamin E in the reduced state. The 
possible site(s) of action of UQHz in relation to that of 
vitamin E will be discussed. 
2. MATERIALS AND METHODS 
The experiments were performed with submitochondrial particles 
(SMP) prepared from beef heart mitochondria by sonication in the 
presence of EDTA according to Lee and Ernster [22]. The particles 
were washed twice with 0.25 M sucrose, once with 0.15 M KC1 and 
then suspended in 0.15 M KCI (20 mg protein/ml). After removing an 
aliquot for testing the ‘native’ SMP. the rest of the suspension was 
lyophilized overnight. Extraction of the lyophilized SMP and reincor- 
poration of UQ-10 were done with pentane as described by Ernster et 
al. [23], with the following minor modifications of the reincorpora- 
tion procedure. The extracted SMP (20 mg protein) were suspended 
in 2 ml pentane containing either 1 mM UQ-10 (Sigma Chemical Co., 
St. Louis, USA) or 0.75 mM vitamin E (DL-cY-tocopherol, Merck 
Biochemica, Darmstadt. Germany), or 1 mM UQ-10 + 0.75 mM 
vitamin E, and shaken in an ice-bath for 5 min. 
In the present work we have tested this hypothesis by 
measuring ascorbate- and ADP-Fe3 + -induced lipid 
peroxidation in beef heart submitochondrial particles 
(SMP) before and after extraction of endogenous coen- 
zyme Q~o (UQ-10) and vitamin E, and after reincor- 
poration of the same components alone or in combina- 
tion into the SMP. The resuhs show that reduced 
UQ-IO (ubiquinol, UQHZ) can inhibit lipid peroxida- 
tion in the absence of vitamin E, and, thus, that its an- 
The contents of UQ-10 and vitamin E in the pentane extracts were 
analyzed by ‘reversed-phase’ HPLC according to Elmberger et al. 
[24], after elution with a linear gradient from 90% of methanol/water 
(9:1) to 100% methanol/isopropanol (4::) for 30 min, while 
monitored continuously at 292 nm. Identification was generally based 
on the commercial samples as standards. 
Lipid peroxidation was determined by following 02 consumption 
polarographically and by measuring the formation of thiobarbituric 
acid reactive substances (mainly malondialdehyde and referred to 
below as MDA) as described by Ernster and Nordenbrand [25]. 
CorrestJondencead~~css: P. Forsmark, Department of Biochemistry, 
hrrhenius Laboratories, Stockholm University, S-106 91 Stockholm, 
Sweden. Fax: (46) (8) 15 3679. 
All incubations were done at 30°C in a 1 ml incubation medium 
consisting of 25 mM Tris-Cl, pH 7.4,0.15 M KCI, and SMP contain- 
ing 0.3-0.5 mg protein. The reaction was started by the addition of 
0.25 mM Na-ascorbate followed by 1 mM ADP + 0.01 mM FeCI, 
(ADP-Fe3+). When indicated, 2 pM antimycin and 5 mM succinate 
were added prior to ascorbate and ADP-Fe’+ . Lipid peroxidation 
was terminated by the addition of 0.1% butylated hydroxytoluene. 
An aliquot of 0.8 ml was removed and mixed with 27 pl 100% 
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trichloroacetic acid for determination of IMDA. Protein was deter- 
mined by the biuret method [26]. All chemicals used were commercial 
products. 
3. RESULTS 
As reported earlier [23], removal of UQ-IO resulted 
in a virtually complete loss of both NADH and suc- 
sinate oxidase activities. Respiration with both 
substrates was reactivated when UQ-10 was reincor- 
porated into the SMP (Table I). Incorporation of 
vitamin E into the pentane-extracted SMP (see below) 
did not stimulate respiration either in the absence or 
presence of UQ-IO. 
Fig. 1 shows the lipid peroxidation induced by ascor- 
bate and ADP-Fe3+ in SMP before (Fig. la,b) and 
after (Fig. Ic,d) lyophilization, and after extraction 
(Fig. le,f) and reincorporation (Fig. lg,h) of UQ-10. 
SMP before and after lyophilization exhibited an 02 
consumption with a concomitant MDA formation (Fig. 
la,c). Addition of antimycin and succinate before 
ascorbate and ADP-Fe3’ inhibited both 0: consump- 
tion and MDA formation (Fig. 1 b,d). The inhibition of 
02 consumption was only partial; this residual activity 
was not affected by increasing amounts of antimycin 
but was inhibited by 1 mM KCN (data not shown). 
However, MDA formation was inhibited by 95%. A 
similar inhibition of MDA formation was obtained with 
antimycin and NADH (0.5 mM), but not with rotenone 
and NADH (data not shown). Malonate (5 mM) 
abolished the effect of succinate. 
After extraction of UQ-10, neither the 02 consump- 
tion nor the formation of MDA was inhibited by an- 
timycin and succinate (Fig. le,f)). The inhibition reap- 
peared, as expected, after reincorporation of UQ-10 
(Fig. lg,h), due to the antioxidant effect of UQHt, in 
accordanse with earlier reports [9,10]. The extracted 
SMP showed a slight inhibition of MDA formation (see 
Fig. If). This could be due to a small amount of 
Table I 
NADH and succinate oxidase activities of beef heart submitochon- 
clrial particles (SMP) before (native) and after lyophilizarion (lyoph.) 
and after pentane extraction (lyoph.,extr.) and after reincorporation 
of coenzyme QIO (UQ-10) and/or vitamin E (Vit. E) 
SMP nanoatoms O/min/mg 
protein 
NADH oxidase Succinate oxidase 
Native 1371 392 
Lyoph. 796 222 
Lyoph., extr. 6 12 
Lyoph., extr., UQ-IO 380 221 
Lyoph., extr., Vit. E 8 16 
Lyoph., extr., UQ-IO + Vit. E 438 135 
SMP (0.4 mg protein) were incubated in 1 ml medium containing 25 
mM Tris-Cl. pH 7.4,0.15 M KCI, 35 PM cytochromec, and when in- 
dicated, 0.96 mM NADH or 5 mM succinate. Temp. 30°C. 
Lyophilization, pentane extraction, and incorporation of UQ-IO’ 
and/or Vit. E were done as described in Materials and Methods. 
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protein-bound UQ-10 that cannot be extracted with the 
method used [27]. This residual UQ-10 might also ex- 
plain the low oxidase activity still exhibited by these 
particles (see Table 1). 
It may also be seen in Fig. 1 that there was an induc- 
tion period of 02 consumption in the native (Fig. la) 
and the lyophilized (Fig. lc) SMP, but not in the SMP 
after pentane extraction (Fig. le) and reincorporation 
of UQ-IO (Fig. Ig). Such an induction period has earlier 
been described with microsomes [X$29] and liposomes 
[30], and attributed to the presence of vitamin E. It 
therefore appeared possible that the pentane extrastion 
in our experiments had removed both UQ-10 and 
vitamin A. As shown in Fig. 2, this indeed was the case; 
the extracted SMP contained no detectable amounts of 
UQ-10 and vitamin E as revealed by HPLC analysis of 
pentane extracts obtained by four successive xtractions 
of the lyophilized SMP. 
When vitamin E was incorporated into the extracted 
SMP, the induction phenomenom reappeared (Fig. li). 
In this particles, MDA formation was only partially in- 
hibited by antimycin -+- succinate (Fig. lj), presumably 
due to a reduction of the cr-tocopheroxyl radical 
through the electron transport system [31], probably via 
residual UQ-10. 
Fig. 3 shows HPLC data on the incorporation of 
UQ-10 and vitamin E into the extracted SMP alone and 
in combination. UQ-10 was incorporated into the SMP 
to a level similar to the original content (Fig. 3b,c), in 
accordance with earlier reports [23,32]. This level was 
virtually independent of whether or not vitamin E also 
was incorporated. The extent of incorporation of 
vitamin E was dependent on the amount of the vitamin 
used. With 0.75 mM vitamin E in the pentane solution 
used for incorporation, it was approximately the same 
as in the native SMP (Fig. 3b,d); at this level of vitamin 
E, the induction period was also approximately equal to 
that found with the native SMP (see Fig. la,i). 
When vitamin E was combined with UQ-IO in the 
reincorporation system (Fig. Qe), the amount of vitamin 
E recovered in the SMP was slightly increased. In this 
case, the induction period for the onset of 02 consump- 
tion was even longer than with vitamin E alone (data 
not shown). This relationship will be elaborated on fur- 
ther in a forthcoming paper. 
4. DISCUSSION 
The present results confirm earlier studies showing 
that reduced UQ-10 (ubiquinol, UQH2) is a potent in- 
hibitor of lipid peroxidation of SMP [9,10]. In addi- 
tion, the data presented here show that the method used 
for the extraction of UQ-10 from the SMP also removes 
vitamin E and, thus, that the presence of vitamin E is 
not a Frerequisite For the function of UQHZ as an an- 
tioxidant, as postulated by Kagan et al. [20] mainly on 
the basis of experiments with non-extracted membrane 
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Fig. I. Ascorbate and ADP-Fe’ ‘-induced lipid peroxidation in SMP before (a,b) and after lyophilization (c,d) and after pentane extraction (e,f) 
and reincorporation of UQ-IO (g,h) and Vit. E (i,j). The lines represent polarographic traces of oxygen consumption, and the numbers at the end 
of the traces indicate the amount of MDA formed in nanomoles. The reaction mixtures were as described in Materials and Methods. Abbreviations: 
SMP, submitochondrial particles; Asc., Na-ascorbate; Antim., antimycin; Succ., succinate. 
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preparations treated with externally added coenzyme Q. 
This direct effect of UQHz on lipid peroxidation may 
consist of a quenching of the L. and/or the LOO 
radical, as schematically illustrated in Fig. 4. Such an 
effect of UQHt has earlier been demonstrated in model 
systems [l-8]. Our results do not exclude the possibility 
that, in addition to its direct effect, UQHZ may also in- 
hibit lipid peroxidation by maintaining vitamin E in the 
reduced state, as proposed by Maguire et al. [31] and 
Mukai et al. [33] which, Ir; turn, quenches LOO. /34]. 
Fig. 2. HPLC chromatogram of non-pooled pentane extracts from 
lyophilized SMP obtained by four successive xtractions (l-4). UQ-IO 
and Vit. E were identified on the basis of retention times as obtained 
with commercial standards. For further details, see Materials and 
Methods. 
4 
UQ-IO in mitochondria may be in a particularly 
favourable position in fulfilling these functions, due to 
its location in the hydrophobic domain of the mem- 
brane, where the initiation of lipid peroxidation takes 
place and, moreover, to its ready access to an efficient 
enzymic reduction device in the form of the ‘Q cycle’, 
(a) (b) 
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Vit.E 
I 
UQ-IO 
minutes 
(cl 
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minutes minutes 
UQ-10 
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Fig. 3. Incorporation of UQ-IO and/or Vit. E into lyophilized, pentane-extracted SMP. (a) Standards. (b) Three pooled pentane extracts from 
lyophilized SMP. (c) Three pooled pentane extracts from lyophilized SMP afler reincorporation of UQ-IO. (d) Three pooled pentam extracts from 
lyophilized StiP after reincorporation of Vit. E. (e) Three pooled pentane extracts from lyophilized SMP after reincorporation of UQ-IO and Vit. 
E. 
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which can regenerate UQHz from UQ-lo-semiquinone 
(UQ - ‘) 1353. The relationship between UQHZ and 
vitamin E in inhibiting lipid peroxidation in biological 
membranes other than mitochondria will require fur- 
ther investigation. 
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Fig. 4. Proposed sites of action of reduced UQ-IO (UQHz) and 
vitamin E (Vit E-OH) as inhibitors of lipid peroxidation. For explana- 
tion, see text. 
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